Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2-12, in Healthy Dogs and Dogs with Clinical Recurrent UTI.
Gilad SegevJ E SykesD J KlumppA J SchaefferE M AntakiB A ByrneR E YaggieJodi L WestroppPublished in: Journal of veterinary internal medicine (2017)
These results suggest ASB E. coli 2-12 is safe and should be investigated in a larger controlled study evaluating clinical UTI in dogs.